Skip to content
Bonalive
  • Deutsch
  • English
  • English US
  • Español
  • Français
  • Italiano
  • Português
Search
  • en-usChange location
      International
    • English (Int.)
    • Deutsch
    • Español
    • Français
    • Italiano
    • Português
    • United States
    • English (US)
Search

News

Back pain – a product of excessive or insufficient exercise?

Patient case: MIS fusion

Highlight of the month in October: Canal-wall down ear procedure

How to prevent the recurrence of benign bone tumors

Indication of the quarter: Bone infection surgery

S53P4 bioactive glass in surgery

3 ways to get to know Bonalive as a workplace

S53P4 bioactive glass remodeling

Pros and cons of 5 bone graft substitutes

4 innovations for an antibiotic-free future

Bonalive Biomaterials appoints Heidi Rantala as new CEO

Diabetic foot infections: Why it’s important to find new sustainable solutions

Cost-effective bone infection surgery – Bonalive® granules

S53P4 bioactive glass in healthcare – International Year of Glass

Bonalive joins Go Blue Campaign

New ways to prevent the recurrence of benign bone tumors

Spine surgery patient cases

Manufacturer Headquarters Distributor
Bonalive Ltd
Tel. +358 401 77 44 00
Biolinja 2, 20750 Turku, Finland
contact@bonalive.com
www.bonalive.com
Bonalive Inc
Tel. +1 (213) 378-2315
640 South San Vicente Blvd
Los Angeles, CA, 90048 USA
contactUS@bonalive.com
www.bonalive.com/us

Copyright © 2026 Bonalive Biomaterials Ltd.
Bonalive® Privacy Policy